NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule

CAMBRIDGE, Mass., Feb. 7, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd.   , a company developing treatments for severe neurodegenerative diseases, today announced that it has received notice...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom , ,Neurosense Therapeutics Ltd ,Nasdaq Stock Market ,Exchange Commission On ,Nasdaq ,Exchange Commission ,Prnewswire Neurosense Therapeutics Ltd ,Sense Therapeutics ,Nasdaq Listing Rule ,Nasdaq Listing Qualifications Staff ,Alon Ben Noon ,Neurosense Therapeutic ,Annual Report ,Neurosense Therapeutics ,Markets ,